StonvexLoading…
StonvexStonvexStonvexCore line items from QCRH's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q3 2026 (Est.) Expected 2026-07-21 | Q3 2024 2024-09-30 | Q2 2024 2024-06-30 | Q1 2024 2024-03-31 | Annual 2023 2023-12-31 |
|---|---|---|---|---|---|
Revenue | $93.46M | $445.12M | $292.54M | $141.91M | $546.09M |
Operating Income | Not available | $89.40M | $59.57M | $27.90M | $126.62M |
Net Income | Not available | $83.63M | $29.11M | $26.73M | $113.56M |
EPS (Diluted) | $1.97 | $4.94 | $3.30 | $1.58 | $6.73 |
Total Assets | Not available | $9.09B | $8.87B | $8.60B | $8.54B |
Total Liabilities | Not available | $8.11B | $7.94B | $7.69B | $7.65B |
Cash & Equivalents | Not available | Not available | Not available | Not available | Not available |
Free Cash Flow OCF − CapEx | Not available | $236.67M | $6.77M | $-9.40M | $361.38M |
Shares Outstanding | Not available | 16.86M | 16.82M | 16.81M | 16.75M |